Literature DB >> 1357180

Mutation analysis of 184 cystic fibrosis families in Wales.

J Cheadle1, J Myring, L al-Jader, L Meredith.   

Abstract

We describe a molecular analysis of 184 cystic fibrosis (CF) families in Wales. To determine accurate frequency data for the CF mutations in the Welsh population, families with at least three Welsh grandparents were strictly regarded as Welsh. Of these 74 families, we have identified approximately 90% of mutations causing CF, with delta F508 accounting for 71.8% and 621 + 1G greater than T 6.7%. We observed a significant difference between the Welsh and Scottish frequencies of 621 + 1G greater than T. To allow the rapid and efficient screening for the more common mutations we modified a multiplex used by Watson et al enabling the detection of delta F508, G551D, and R553X simultaneously with 621 + 1G greater than T. In parallel to this system we ran the Cellmark Diagnostics ARMS multiplex kit, which detects delta F508, 621 + 1G greater than T, G551D, and G542X. RFLP analysis of the 184 families shows that the delta F508 chromosomes are almost exclusively found on the B haplotype (XV2c 1, KM19 2); the other CF mutations have more heterogeneous backgrounds. Strong haplotype correlations exist between the markers XV2c, KM19, D9, and G2 and the other CF mutations. Haplotype data suggest that there are at least seven mutations that remain to be identified in these families.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357180      PMCID: PMC1016096          DOI: 10.1136/jmg.29.9.642

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  18 in total

1.  A new missense mutation (R1283M) in exon 20 of the cystic fibrosis transmembrane conductance regulator gene.

Authors:  J P Cheadle; A L Meredith; L N al-Jader
Journal:  Hum Mol Genet       Date:  1992-05       Impact factor: 6.150

2.  A 3' splice site consensus sequence mutation in the cystic fibrosis gene.

Authors:  H Guillermit; P Fanen; C Ferec
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

3.  The haplotype distribution of the delta F508 mutation in cystic fibrosis families in Scotland.

Authors:  I McIntosh; A Curtis; M L Lorenzo; M Keston; A J Gilfillan; G Morris; D J Brock
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

4.  Mutation analysis at the cystic fibrosis locus in the British population.

Authors:  A Harris; F Beards; C Mathew
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

5.  Discrimination between recurrent mutation and identity by descent: application to point mutations in exon 11 of the cystic fibrosis (CFTR) gene.

Authors:  J Reiss; D N Cooper; J Bal; R Slomski; G R Cutting; M Krawczak
Journal:  Hum Genet       Date:  1991-08       Impact factor: 4.132

6.  The incidence of different cystic fibrosis mutations in the Scottish population: effects on prenatal diagnosis and genetic counselling.

Authors:  A E Shrimpton; I McIntosh; D J Brock
Journal:  J Med Genet       Date:  1991-05       Impact factor: 6.318

7.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

8.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

9.  Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients.

Authors:  M Dean; M B White; J Amos; B Gerrard; C Stewart; K T Khaw; M Leppert
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

10.  Screening for carriers of cystic fibrosis through primary health care services.

Authors:  E K Watson; E Mayall; J Chapple; M Dalziel; K Harrington; C Williams; R Williamson
Journal:  BMJ       Date:  1991-08-31
View more
  5 in total

1.  Cost effectiveness of antenatal screening for cystic fibrosis.

Authors:  H S Cuckle; G A Richardson; T A Sheldon; P Quirke
Journal:  BMJ       Date:  1995-12-02

2.  Prevalence of cystic fibrosis mutations in the Grampian region of Scotland.

Authors:  Z H Miedzybrodzka; J C Dean; G Russell; J A Friend; K F Kelly; N E Haites
Journal:  J Med Genet       Date:  1993-04       Impact factor: 6.318

3.  Uptake of cystic fibrosis testing in primary care: supply push or demand pull?

Authors:  H Bekker; M Modell; G Denniss; A Silver; C Mathew; M Bobrow; T Marteau
Journal:  BMJ       Date:  1993-06-12

4.  The impact of population based screening for carriers of cystic fibrosis.

Authors:  H Bekker; G Denniss; M Modell; M Bobrow; T Marteau
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

5.  Cystic fibrosis with homozygous R553X mutation in a Taiwanese child.

Authors:  Hui-Ju Chen; Shuan-Pei Lin; Hung-Chang Lee; Chih-Ping Chen; Nan-Chang Chiu; Han-Yang Hung; Schu-Rern Chern; Chih-Kuang Chuang
Journal:  J Hum Genet       Date:  2005-11-10       Impact factor: 3.172

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.